OKYO Pharma Limited (OKYO)

NASDAQ: OKYO · Real-Time Price · USD

1.400

0.00 (0.00%)

At close: Sep 14, 2026, 4:00 PM EDT

1.400

0.00 (0.00%)

After-hours: Sep 14, 2026, 4:10 PM EDT

OKYO Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Quarter	Current	H2 2026	H1 2026	H2 2025	H1 2025	H2 2024	H1 2024	H2 2023	H1 2023	H2 2022	H1 2022
Period Ending	Sep '26 Sep 14, 2026	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Sep '24 Sep 30, 2024	Mar '24 Mar 31, 2024	Sep '23 Sep 30, 2023	Mar '23 Mar 31, 2023	Sep '22 Sep 30, 2022	Mar '22 Mar 31, 2022	Sep '21 Sep 30, 2021
Market Capitalization	73	84	75	43	35	50	52	34	42	109	66
Market Cap Growth (YoY)	-10.39%	96.04%	117.95%	-12.97%	-33.89%	47.06%	22.98%	-68.99%	-35.78%	46.71%	793.51%
Enterprise Value	53	80	74	42	34	48	50	33	40	103	59
Last Close Price	1.40	1.61	2.00	1.27	1.02	1.49	1.85	1.32	1.95	5.14	4.43

Price Ratios

Fiscal Quarter	Current	H2 2026	H1 2026	H2 2025	H1 2025	H2 2024	H1 2024	H2 2023	H1 2023	H2 2022	H1 2022
Period Ending	Sep '26 Sep 14, 2026	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Sep '24 Sep 30, 2024	Mar '24 Mar 31, 2024	Sep '23 Sep 30, 2023	Mar '23 Mar 31, 2023	Sep '22 Sep 30, 2022	Mar '22 Mar 31, 2022	Sep '21 Sep 30, 2021
PB Ratio	5.96	6.85	-22.02	-7.77	-4.78	-8.42	-	-16.40	-123.02	36.84	13.30
P/TBV Ratio	5.96	6.85	-	-	-	-	-	-	-	36.84	13.30

Financial Efficiency

Fiscal Quarter	Current	H2 2026	H1 2026	H2 2025	H1 2025	H2 2024	H1 2024	H2 2023	H1 2023	H2 2022	H1 2022
Period Ending	Sep '26 Sep 14, 2026	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Sep '24 Sep 30, 2024	Mar '24 Mar 31, 2024	Sep '23 Sep 30, 2023	Mar '23 Mar 31, 2023	Sep '22 Sep 30, 2022	Mar '22 Mar 31, 2022	Sep '21 Sep 30, 2021
Debt / Equity Ratio	-	-	-0.05	-	0	-	-	-1.08	-	-	0.02
Net Debt / Equity Ratio	-1.67	-1.67	1.18	0.28	0.14	0.14	-	0.89	2.05	-0.92	-1.03
Net Debt / EBITDA Ratio	2.42	2.42	0.65	0.22	0.10	0.05	-	0.14	0.08	0.43	0.91
Net Debt / FCF Ratio	3.47	3.47	1.30	0.86	0.34	0.09	-	0.25	0.12	0.49	1.26
Return on Capital Employed (ROCE)	-68.90%	-68.90%	183.10%	127.80%	143.30%	267.90%	-	615.00%	2522.10%	-213.30%	-111.80%

Yields

Fiscal Quarter	Current	H2 2026	H1 2026	H2 2025	H1 2025	H2 2024	H1 2024	H2 2023	H1 2023	H2 2022	H1 2022
Period Ending	Sep '26 Sep 14, 2026	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Sep '24 Sep 30, 2024	Mar '24 Mar 31, 2024	Sep '23 Sep 30, 2023	Mar '23 Mar 31, 2023	Sep '22 Sep 30, 2022	Mar '22 Mar 31, 2022	Sep '21 Sep 30, 2021
Earnings Yield	-12.18%	-10.59%	-6.13%	-10.92%	-30.97%	-33.98%	-31.52%	-37.75%	-19.07%	-5.06%	-8.08%
FCF Yield	-8.09%	-7.03%	-4.12%	-4.21%	-8.52%	-19.16%	-20.88%	-21.81%	-13.77%	-5.11%	-6.15%
Buyback Yield / Dilution	5.40%	17.86%	-11.46%	-37.70%	-30.56%	-44.17%	-18.81%	-41.86%	-54.52%	-52.75%	-38.06%

SEC Filings: 10-K · 10-Q